Although a link between MYC family proteins and MHC-I heavy chain gene expression was described over 30 years ago in neuroblastoma and melanoma cell lines50,51, this link has not been explored in breast cancer, and its significance for immune checkpoint inhibitor response has not been investigated in human patient samples or in vivo cancer models. This evidence concerns the gene MYC and breast carcinoma.